Epitope mirroring between the malaria surface proteins PfGARP and PIESP2 identifies a knob-associated complex in

Christopher J Schwake1, Rachel M Krueger2, Feier Chen3

  • 1Program in Cellular, Molecular, and Developmental Biology, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts, USA; Department of Developmental, Molecular, and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.

Insights

Researchers identified a new malaria parasite protein, PIESP2, on infected red blood cells. This discovery offers potential for new diagnostic tools and therapeutic strategies against severe malaria, particularly cerebral and pregnancy-associated malaria.

Area of Science:

  • Parasitology
  • Immunology
  • Molecular Biology

Background:

  • Malaria, caused by Plasmodium falciparum, leads to severe disease via infected red blood cell adhesion to endothelium.
  • This adhesion involves parasite knobs and PfEMP1, but effective therapies targeting this pathway are lacking.
  • Plasmodium falciparum glutamic acid-rich protein (PfGARP) binds erythrocyte Band 3, suggesting a role in cytoadherence.

Purpose of the Study:

  • To investigate the composition of the PfGARP complex.
  • To characterize a monoclonal antibody (GM7mAb) targeting PfGARP.
  • To identify novel components associated with parasite knobs and cytoadherence.

Main Methods:

  • Phage display cDNA technology to identify PfGARP.
  • Generation and characterization of GM7mAb targeting PfGARP.
  • Mass spectrometry and PfGARP-null parasite lines to identify GM7mAb epitope.

Main Results:

  • Identified Parasite-Infected Erythrocyte Specific Protein-2 (PIESP2) as the target of GM7mAb's reverse epitope.
  • Demonstrated PIESP2 localization to the surface of parasite-induced knobs.
  • Validated GM7mAb as a potential diagnostic tool for detecting anti-PIESP2 antibodies.

Conclusions:

  • PIESP2 is a novel knob-associated protein in P. falciparum-infected erythrocytes.
  • GM7mAb can be used for detecting antibodies against PIESP2, aiding malaria diagnosis.
  • Targeting the PIESP2 complex may offer new strategies to combat severe malaria.